Health ❯ Healthcare

Clinical Trials

Drug Development Phase 3 Trials Drug Efficacy Patient Outcomes Phase III Trials Research Studies Randomized Controlled Trials Efficacy Studies Cancer Research Cancer Treatment

FDA Approves Bizengri for NRG1 Fusion–Positive Cholangiocarcinoma

The decision uses a priority voucher program to speed a targeted option for a small group with few treatments.

Stories older than 24h

NEJM Study and FDA Access Advance Daraxonrasib for Pancreatic Cancer

Moderna’s mRNA Flu Shot Tops Standard Vaccine in Large Phase 3 Trial

Study Details VeloCD Blood Method to Predict Illness Trajectory

Lithium Chloride Rewires Alzheimer’s-Linked Pathways in Cell Study

AI Blood Test Maps Tumor Neighborhoods and Predicts Immunotherapy Response

Avalo Therapeutics Reports Positive Phase 2 HS Results, Prices $375 Million Offering

Home Blood Test and Online Checks Flag Alzheimer’s Risk in Small Study

Nuvation Bio Reports Q1 Growth as Iptrozy Moves Earlier in ROS1 Lung Cancer Care

FDA Authorizes Early Access to Daraxonrasib for Pancreatic Cancer Patients

FDA Approves Auvelity as First Non‑Antipsychotic for Alzheimer’s Agitation

FDA Panel Rejects AstraZeneca Breast Cancer Drug, Backs Prostate Therapy

FDA Clears Vepdegestrant, First PROTAC Cancer Drug, for ESR1‑Mutated Breast Cancer

Moderna Beats Q1 Forecast as Overseas COVID Shot Sales Rebound

Five-Day Brain Stimulation Improves Social Communication in Children With Autism

New CAR-T Designs Deliver Low-Dose Remissions and Expose a Senescence Risk

Mayo Clinic AI Flags Pancreatic Cancer on CT Scans Up to Three Years Early

Pfizer’s Elrexfio Posts Phase 3 PFS Win Over Standard Multiple Myeloma Regimen

FDA Launches First Real-Time Clinical Trial Pilot With AstraZeneca and Amgen

Erasca Shares Plunge After Trial Death and Patent Challenge